![]() |
市場調查報告書
商品編碼
2130872
硼酸親和性和層析法市場規模、佔有率和成長分析:按產品類型、應用、最終用戶、方法和地區分類 - 產業預測,2026-2033年Boronate Affinity Chromatography Market Size, Share, and Growth Analysis, By Product Type, By Application, By End User, By Technique, By Region - Industry Forecast 2026-2033 |
||||||
2024 年全球硼酸親和性和層析法市場價值為 4.72 億美元,預計到 2025 年將成長至 2033 年的 10.1671 億美元,在預測期(2026-2033 年)內複合年成長率為 8.9%。
全球硼酸親和性和層析法市場專注於以樹脂為基礎的技術,這些技術能夠選擇性地捕捉生物分子,特別是糖蛋白和糖複合物,包括順式二醇。市場成長的驅動力在於生物製藥(尤其是單株抗體)需求的不斷成長,這些產品需要高純度純化以滿足嚴格的監管要求。隨著產業逐漸摒棄傳統的蛋白A層析法,人們的關注點轉向了能夠維持天然糖鏈結構以實現精確糖工程的硼酸鹽介質。隨著生物製程製程向連續發展,穩健的在線純化至關重要,而硼酸親和性和柱具有結合速度快、易於再生等優點。隨著製造商加強對自動化和生產規模的投資,樹脂供應商正在開發更先進、高容量的載體,從而促進市場滲透、加快法規核准,並推動生物製藥領域的創新應用。
全球硼酸親和性和層析法市場成長要素
對能夠維持產品完整性的高選擇性純化平台的需求,正在推動全球硼酸親和性和層析法市場的成長。治療性蛋白質和抗體生產商正擴大利用這項技術,因為它能夠精確結合順式二醇,並簡化下游製程。隨著產業優先考慮快速進入市場和成本效益,硼酸親和性和層析法在研發和商業應用領域的應用都在不斷擴展。此外,不斷成長的生物製藥研發管線也進一步推動了對此方法的需求,使其成為早期研發和大規模生產環境中關鍵純化難題的理想解決方案。
全球硼酸親和性和層析法市場面臨的限制因素
硼酸配體的製備及其與高純度載體基質的可靠結合需要多個精細步驟、專用試劑和嚴格的品質保證。這種複雜性導致材料成本遠高於傳統層析法介質,為小規模實驗室和新興生物技術公司帶來了巨大的經濟挑戰。當資金被分配給關鍵研究舉措時,對這些先進親和性和樹脂的投資可能會被推遲或限制。因此,高成本阻礙了許多相關人員採用這項技術,儘管其具有顯著的技術優勢,但仍抑制了整體市場成長。
硼酸親和性和層析法的全球市場趨勢
受高純度單株抗體和高糖基化蛋白需求不斷成長的推動,全球硼酸親和性和層析法市場正經歷顯著成長。隨著生技製藥企業日益重視下游製程的效率,硼酸親和性和層析法正成為選擇性捕捉聚醣、提高純化效率和確保產品均一性的重要工具。將這些樹脂整合到連續純化平台是關鍵的市場趨勢,可降低批間差異,並滿足產業對穩健製程的需求。該技術與生物製藥研發的創新追求相契合,有助於企業遵守嚴格的監管標準,並在快速變化的環境中增強競爭優勢。
Global Boronate Affinity Chromatography Market size was valued at USD 472.0 Million in 2024 and is poised to grow from USD 514.01 Million in 2025 to USD 1016.71 Million by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).
The Global Boronate Affinity Chromatography market focuses on a resin-based technology adept at selectively capturing cis-diol-containing biomolecules, especially glycoproteins and glycoconjugates. The market's growth is fueled by the rising demand for biologics, particularly monoclonal antibodies, which necessitate high-purity purification compliant with stringent regulatory requirements. Transitioning from traditional protein A chromatography, industry interest has shifted towards boronate media to preserve native glycan structures for precise glyco-engineering. With the evolution towards continuous bioprocessing, robust inline purification is essential, and boronate affinity columns provide rapid binding kinetics and ease of regeneration. As manufacturers invest in automation and scale-up production, resin suppliers are developing advanced, higher-capacity media, thereby enhancing market reach, easing regulatory acceptance, and promoting innovative applications in biopharma.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Boronate Affinity Chromatography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Boronate Affinity Chromatography Market Segments Analysis
Global boronate affinity chromatography market is segmented by product type, application, end user, technique and region. Based on product type, the market is segmented into Boronate Affinity Resins, Boronate Affinity Columns and Boronate Affinity Kits. Based on application, the market is segmented into Glycoprotein Purification, Glycan Analysis, Biomarker Research and Drug Discovery. Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Contract Research Organizations. Based on technique, the market is segmented into Analytical Chromatography and Preparative Chromatography. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Boronate Affinity Chromatography Market
The demand for high-selectivity purification platforms that maintain product integrity is driving growth in the global boronate affinity chromatography market. Manufacturers of therapeutic proteins and antibodies are increasingly utilizing this technology due to its ability to provide precise binding to cis-diols, which streamlines downstream processing. As the industry prioritizes rapid market entry and cost efficiency, the adoption of boronate affinity chromatography is expanding across both research and commercial applications. Additionally, the increasing pipeline of biologics further propels the demand for this method, establishing it as a preferred solution for critical purification challenges in early-stage development and large-scale production settings.
Restraints in the Global Boronate Affinity Chromatography Market
The production of boronate ligands and their secure attachment to high-purity support matrices entails several meticulous steps, requiring specialized reagents and rigorous quality assurance. This complexity elevates the costs of materials considerably beyond those associated with traditional chromatography media, posing financial challenges for smaller laboratories and emerging biotech firms. When funding is directed toward essential research initiatives, the investment in these advanced affinity resins may be postponed or restricted. As a result, the high costs can discourage many from adopting this technology, hindering its overall market growth despite its significant technical benefits.
Market Trends of the Global Boronate Affinity Chromatography Market
The Global Boronate Affinity Chromatography market is witnessing significant growth driven by the expanding demand for high-purity monoclonal antibodies and advanced glyco-engineered proteins. As biopharmaceutical manufacturers increasingly prioritize streamlined downstream processing, boronate affinity chromatography emerges as an essential tool for selective glycan capture, enhancing purification efficiency and product consistency. The integration of these resins into continuous purification platforms is a key market trend, reducing batch variability and supporting industry demands for robust processes. This technology aligns with the pursuit of innovation in biologics development, facilitating compliance with stringent regulatory standards and fostering competitive advantages in a rapidly evolving landscape.